Westfield Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-806,400
| Closed | -$97.8M | – | 263 |
|
|
2023
Q3 | $97.8M | Buy |
806,400
+230,618
| +40% | +$28M | 0.67% | 40 |
|
|
2023
Q2 | $65.9M | Sell |
575,782
-226,876
| -28% | -$26M | 0.42% | 94 |
|
|
2023
Q1 | $111M | Buy |
802,658
+50,962
| +7% | +$7.02M | 0.78% | 32 |
|
|
2022
Q4 | $97.4M | Buy |
751,696
+156,880
| +26% | +$20.3M | 0.75% | 38 |
|
|
2022
Q3 | $65.8M | Buy |
+594,816
| New | +$65.8M | 0.52% | 65 |
|
|
2021
Q1 | – | Sell |
-279,328
| Closed | -$47.6M | – | 280 |
|
|
2020
Q4 | $47.6M | Sell |
279,328
-62,827
| -18% | -$10.7M | 0.28% | 123 |
|
|
2020
Q3 | $48M | Buy |
342,155
+40,010
| +13% | +$5.62M | 0.31% | 105 |
|
|
2020
Q2 | $48.4M | Sell |
302,145
-43,941
| -13% | -$7.05M | 0.33% | 101 |
|
|
2020
Q1 | $33.9M | Buy |
346,086
+19,808
| +6% | +$1.94M | 0.3% | 103 |
|
|
2019
Q4 | $42.1M | Buy |
326,278
+5,717
| +2% | +$738K | 0.3% | 115 |
|
|
2019
Q3 | $24.1M | Buy |
320,561
+46,704
| +17% | +$3.52M | 0.19% | 141 |
|
|
2019
Q2 | $41.6M | Sell |
273,857
-17,630
| -6% | -$2.68M | 0.31% | 113 |
|
|
2019
Q1 | $34.7M | Buy |
291,487
+36,385
| +14% | +$4.34M | 0.26% | 126 |
|
|
2018
Q4 | $27.8M | Buy |
255,102
+160,447
| +170% | +$17.5M | 0.24% | 131 |
|
|
2018
Q3 | $15.3M | Buy |
+94,655
| New | +$15.3M | 0.11% | 188 |
|